Navigation Links
Breast Cancer Recurrence Rates Appear Different When Radiation Used
Date:4/30/2011

By Kathleen Doheny
HealthDay Reporter

FRIDAY, April 29 (HealthDay News) -- Patients with early stage breast cancers are commonly treated with surgery or surgery plus radiation, and radiation is widely believed to cut local recurrence rates by about half.

Now, researchers report that they have found that surgery plus radiation does cut local recurrences, but appears to increase the risk of invasive breast cancers later.

"I don't want people to think radiation is bad," said study author Dr. Janie Weng Grumley, a fellow in breast oncology at the University of Southern California Keck School of Medicine. "We know there is less recurrence with radiation."

Grumley's team evaluated 1,014 patients with early breast cancer, known as ductal carcinoma in situ. Of these, 651 had surgery alone while 363 had surgery plus radiation.

The 10-year probability of any recurrence at the same site was 30 percent for the surgery group and 18 percent for the combination group. However, when cancer does return in those who get the combination treatment, her study showed the patterns are different.

"The patients who got radiation recurred a lot later than the patients who didn't," she said. The average time to the cancer recurring in the same site was 7.5 years for those who had radiation plus surgery and 4.4 years for those who had surgery only.

However, "surgery plus radiation had more invasive recurrence," she said. Thirty-seven percent of the surgery group had an invasive recurrence at the same site, but 57 percent of the combination group did, she said.

While 28 percent of the recurrences were in different quadrants of the breast for the combination patients -- essentially new cancers -- only 10 percent of the recurrences in surgery-only patients were in new quadrants.

The survival rate among the surgery group at 10 years was 99.7 percent, compared to 98.3 percent for the combination group, the study found.

The study leaves many questions unanswered. "Is the radiation causing more new cancers?" Grumley wondered.

The research also has several limitations: The average follow-up for the surgery group was six years, while the average follow-up for the combination group was a little over nine years. "One could say the follow-up is longer, and maybe we would find the same thing if we followed the surgery-only group," Grumley said.

The findings were slated to be presented Friday at the American Society of Breast Surgeons meeting, in Washington, D.C.

The finding should be considered very preliminary, said Dr. Otis Brawley, chief medical and scientific officer for the American Cancer Society and professor of oncology and epidemiology at the Emory University School of Medicine, in Atlanta.

"I would say you have to look at all abstracts from scientific meetings with a grain of salt," Brawley said. The research has not yet been exposed to rigorous review and critique by the researchers' colleagues, he said. If a study is the first of its kind, it must be replicated by others to confirm the finding.

Grumley said the message for now is that women should be aware of the different patterns found. "Really, the message should be we should monitor these patients beyond the [typical] five years," she added.

More information

To learn more about ductal carcinoma in situ, visit the U.S. National Institutes of Health.

SOURCES: Otis Brawley, M.D., chief medical and scientific officer, American Cancer Society, and professor, oncology and epidemiology, Emory University School of Medicine, Atlanta; Janie Weng Grumley, M.D., fellow, breast oncology, University of Southern California Keck School of Medicine; April 29, 2011, presentation, American Society of Breast Surgeons meeting, Washington, D.C.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Recurrence Rates Appear Different When Radiation Used
(Date:5/27/2017)... ... 27, 2017 , ... In any business, follow up is critical to success. ... team at presenting treatment, there will always be some patients who can’t or won’t ... on best practices when it comes to presenting treatment. After the patient leaves, ...
(Date:5/26/2017)... NY (PRWEB) , ... May 26, 2017 , ... Mediaplanet ... & Wound Care" campaign in USA Today, which will educate readers on how to ... of the campaign, a large focus is placed on melanoma. Dancing with the Stars ...
(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology ... to focus on current legislative activity and the latest regulatory concerns impacting RBMA ... Sunday, Sept. 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, ...
(Date:5/26/2017)... Minneapolis, MN (PRWEB) , ... May 26, 2017 , ... ... five U.S. states with the healthiest seniors are located in the Midwest. With the ... 2060, more and more people are concerned with both the quality and affordability of ...
(Date:5/26/2017)... ... , ... On May 24, the Congressional Budget Office (CBO) projected that the ... 4, would result in 23 million Americans losing their health insurance by 2026 as ... and Affordable Care Act (ACA). , “It is clear from the CBO analysis ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/22/2017)... , May 22, 2017  As the ... a whole continue to make the revolutionary shift ... increasingly important for ensuring positive patient outcomes and ... stakeholders are shifting focus away from clinical trials ... effects of long-term specialty drug therapy utilization in ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
Breaking Medicine Technology: